92
Views
0
CrossRef citations to date
0
Altmetric
Guest Editorial

Genetics and Genomics: Unraveling New Opportunities for Addiction Treatment and Education

, PhD, RN, PMHNP-BC, CARN, FAANP & , MSN, RN, PMHNP-BC
Pages 93-96 | Published online: 02 May 2012

REFERENCES

  • American Nurses Association (2009). The essentials of genetic and genomic nursing: Competencies, curricular guidelines, and outcome indicators. 2nd edition. Silver Springs, MD.
  • Anton, R. F., Oroszi, G., O'Malley, S., Couper, D., Swift, R., Pettinati, H., & Goldman, D. (2008). An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: Results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Archives of General Psychiatry, 65(2), 135–144.
  • Arias, A. J., Armeli, S., Gelernter, J., Covault, J., Kallio, A., Karhuvaara, S., Kranzler, R. H. (2008). Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers. Alcoholism: Clinical and Experimental Research, 32(7), 1159–1166.
  • Bart, G., Kreek, M. J., Ott, J., LaForge, K. S., Proudnikov, D., Pollak, L., & Heilig, M. (2004). Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden. Neuropsychopharmacology, 30(2), 417–422.
  • Bond, C., LaForge, K. S., Tian, M., Melia, D., Zhang, S., Borg, S., … Yu, L. (1998). Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphins binding and activity: Possible implications for opiate addictions. Proceedings of the National Academy of Sciences, 95(16), 9608–9613.
  • Bonoiu A. C., Mahajan, S. D., Ding, H., Roy, I., Yong, K., Kumar, R., … Prasad, P. N. (2009). Nanotechnology approach for drug addiction therapy: Gene silencing using delivery of gold nanorod siRNA nanoplex in dopaminergic neurons. Proceedings of the National Academy of Sciences of the United States of Americ, 106(1), 5546–5550. doi: 10.1073/pnas.0901715106.
  • Chi, K. (2011). Vaccines move forward against a range of addictions. Nature Medicine, 17(2), 146. doi:10.1038/nm0211–146.
  • Doehring, A., Geisslinger, G., & Lotsch, J. (2011) Epigenetics in pain and analgesia: An imminent research field. European Journal of Pain, 15, 11–16.
  • Green, E. D., Guyer, M. S., & National Human Genome Research Institute (2011). Charting a course for genomic medicine from base pairs to bedside. Nature, 470, 204–213. doi: 10.1038/nature09764.
  • Ito, H., Matsuo, K., Wakai, K., Saito, T., Kumimoto, H, Okuma, K., … Hamajima, N. (2006). An intervention study of smoking cessation in feedback on genetic cancer susceptibility in Japan. Preventative Medicine, 42, 102–108. Retrieved from Sciencedirect.com
  • Kang, T., Woo, S., Park, H., Lee, Y., & Roh, J. (2009). Comparison of genetic polymorphisms of CYP2E1, ADH2, and ALDH2 genes involved in alcohol metabolism in Koreans and four other ethnic groups. Journal of Clinical Pharmacy & Therapeutics, 34(2), 225–230. Retrieved from EBSCOhost.
  • Malaiyandi, V., Lerman, C., Benowitz, N. L., Jepson, C., Patterson, F., & Tyndale, R. F. (2006). Impact of CYP2A6 genotype on pretreatment smoking behavior and nicotine levels from and usage of nicotine replacement therapy. Molecular Psychiatry, 11(4), 400–409.
  • Mroziewicz, M. M. & Tyndale, R. F. (2010). Pharmacogenetics: A tool for identifying genetic factors in drug dependence and response to treatment. Addiction Science & Clinical Practice, 5(2) 17–29. Retrieved from http://www.drugabuse.gov/PDF/ascp/vol5no2/Tool.pdf
  • National Institute on Drug Abuse. NIDA InfoFacts: Nationwide trends. (2011). Retrieved from http://www.drugabuse.gov/infofacts/nationtrends.html.
  • Quevedo Garcia, S. P., Greco, K. E., & Loescher, L. J. (2011). Teaching strategies to incorporate genomics education into academic nursing curricula. Journal of Nursing Education, 50(11), 612–619.
  • Ray, R., Tyndale, R. F., & Lerman, C. (2008). Nicotine dependence pharmacogenetics: Role of genetic variation in nicotine-metabolizing enzymes. Journal of Neurogenetics, 23, 252–261. Doi: 10.1080/01677060802572887.
  • Renthal, W. & Nestler, E. J. (2008). Epigenetic mechanisms in drug addiction. Trends in Molecular Medicine, 14(8), 341–50.
  • Volkow, N. D. (2010a). Cocaine: Abuse and addiction. Research Report Series. Retrieved from http://http://www.drugabuse.gov/ResearchReports/Cocaine/cocaine.html.
  • Volkow, N. D. (2010b). Marijuana abuse. Research Report Series. Retrieved from http://www.drugabuse.gov/ResearchReports/Marijuana/default.html.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.